Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux EPISEQ SARS-COV-2 Software

BioMérieux has launched EPISEQ SARS-COV-2, a sequencing- and cloud-based software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants. 

The SARS-CoV-2 EPISEQ application is intended to identify SARS-CoV-2 variants using samples from positive patients. The platform is automatically updated weekly and identifies variants based on international nomenclatures including new variants of concern as defined by the World Health Organization and the US Centers for Disease Control and Prevention. The EPISEQ SARS-COV-2 software is compatible with llumina, Oxford Nanopore, and Thermo Fisher Scientific sequencing platforms and is intended to be easy to use for microbiology labs without bioinformatics knowledge or computing resources. The application also permits the export of viral genome assemblies and mutations in order to facilitate reporting to national public health authorities and for epidemiology studies.

EPISEQ SARS-COV-2 is the third application hosted on the EPISEQ platform, along with EPISEQ CS for bacterial hospital acquired infections and EPISEQ 16S for microbiome analysis.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.